MYC plays an important role in intrinsic ibrutinib resistance in MCL, probably by inhibiting miR16-1 and miR15a, two tumor suppressor miRNAs involved in MCL pathogenesis. The gene discussed is MYC; the disease is mantle cell lymphoma.